American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 316-321.e1 , 1 February 2010

Subretinal Hemorrhages Associated with Age-Related Macular Degeneration in Patients Receiving Anticoagulation or Antiplatelet Therapy

  • Claudia Kuhli-Hattenbach

      Affiliations

    • Klinik für Augenheilkunde, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany
    • Corresponding Author InformationInquiries to Claudia Kuhli-Hattenbach, Department of Ophthalmology, Johann Wolfgang Goethe University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
    • ,
  • Ina Barbara Fischer

      Affiliations

    • Klinik für Augenheilkunde, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany
    • ,
  • Rainer Schalnus

      Affiliations

    • Klinik für Augenheilkunde, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany
    • ,
  • Lars-Olof Hattenbach

      Affiliations

    • Klinik für Augenheilkunde, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany
    • Augenklinik des Klinikums Ludwigshafen, Ludwigshafen am Rhein, Germany

,Accepted 28 August 2009.

References 

  1. Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol. 1997;42:195–213
  2. Bennett SR, Blodi CF, Folk JC. Factors prognostic of visual outcome in patients with subretinal hemorrhage involving the fovea. Am J Ophthalmol. 1990;109:33–37
  3. Avery RL, Fekrat S, Hawkins BS, et al. Natural history of subfoveal hemorrhage in age-related macular degeneration. Retina. 1996;16:183–189
  4. Jneid H, Bhatt DL. Advances in antiplatelet therapy. Expert Opin Emerg Drugs. 2003;8:349–363
  5. Faxon DP. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices. Rev Cardiovasc Med. 2005;6:S3–S14
  6. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest. 2001;119(suppl):108S–121S
  7. Schulman S. Care of patients receiving long-term anticoagulant therapy. N Engl J Med. 2003;349:675–683
  8. Barequet IS, Sachs D, Priel A, et al. Phacoemulsification of cataract in patients receiving Coumadin therapy: ocular and hematologic risk assessment. Am J Ophthalmol. 2007;144:719–723
  9. Dayani PN, Siddiqi OK, Holekamp N. Safety of intravitreal injections in patients receiving warfarin anticoagulation. Am J Ophthalmol. 2007;144:451–445
  10. Law SK, Song BJ, Kurbanyan K, Yang T, Caprioli J. Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy. Am J Ophthalmol. 2008;145:736–746
  11. Tilanus MAD, Vaandrager W, Cuypers MHM, Verbeek AM, Hoyng CB. Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2000;238:482–485
  12. Yang SS, Fu AD, McDonald HR, Johnson RN, Ai E, Jumper JM. Massive spontaneous choroidal hemorrhage. Retina. 2003;23:139–144
  13. Chang WJ, Nowinski TS, Repke CS, Buerger DG. Spontaneous orbital hemorrhage in pregnant women treated with subcutaneous heparin. Am J Ophthalmol. 1996;122:907–908
  14. Kageler WV, Moake JL, Garcia CA. Spontaneous hyphema associated with ingestion of aspirin and ethanol. Am J Ophthalmol. 1976;82:631–634
  15. Caronia RM, Sturm RT, Fastenberg DM, Berke SJ, Weintraub J. Bilateral secondary angle-closure glaucoma as a complication of anticoagulation in a nanophthalmic patient. Am J Ophthalmol. 1998;126:307–309
  16. Brown GC, Tasman WS, Shields JA. Massive subretinal hemorrhage and anticoagulant therapy. Can J Ophthalmol. 1982;17:227–230
  17. Greenfield DS, Liebmann JM, Ritch R. Hyphema associated with pupillary dilation in a patient with exfoliation glaucoma and warfarin therapy. Am J Ophthalmol. 1999;128:98–100
  18. Lewis H, Sloan SH, Foos RY. Massive intraocular hemorrhage associated with anticoagulation and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1988;226:59–64
  19. El Baba J, Jarett WH, Harbin TS, et al. Massive hemorrhage complicating age-related macular degeneration (Clinicopathological correlation and role of anticoagulation). Ophthalmology. 1986;93:1581–1592
  20. Weir C, Nolan DJ, Holding D, Hammer H. Intraocular haemorrhage associated with anticoagulant therapy. Acta Ophthalmol Scand. 2000;78:492–493
  21. Knox FA, Johnston PB. Spontaneous suprachoroidal hemorrhage in a patient with age-related macular degeneration on excessive anticoagulation therapy. Eye. 2002;16:669–670
  22. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration (Results of a randomized clinical trial). Arch Ophthalmol. 1991;109:1220–1231
  23. Glatt H, Machamer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762–773
  24. Toth CA, Morse LS, Hjelmeland LM, Landers MB. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol. 1991;109:723–729
  25. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina. 1991;11:250–258
  26. Hattenbach LO, Klais C, Koch FJ, Gümbel HOC. Intravenous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. 2001;108:1485–1492
  27. Bloome MA, Ruiz RS. Massive spontaneous subretinal hemorrhage. Am J Ophthalmol. 1978;86:630–637
  28. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfare (Incidence and prediction by factors known at the start of the outpatient therapy). Am J Med. 1989;78:144–152
  29. Serebruyani VL, Steinhuble SR, Berger PB, et al. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Card. 2005;95:1218–1222
  30. Fanucchi S, Persico A. Warfarin-associated intracerebral hemorrhage. Neurol Sci. 2008;29:S266–S268
  31. Wong JS. Spontaneous suprachoroidal hemorrhage in a patient receiving low-molecular-weight heparin (fraxiparine) therapy. Aust N Z J Ophthalmol. 1999;27:433–434

PII: S0002-9394(09)00659-X

doi: 10.1016/j.ajo.2009.08.033

American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 316-321.e1 , 1 February 2010

Article Tools

* Image Usage & Resolution